A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes
Phase of Trial: Phase II
Latest Information Update: 21 Oct 2016
Price : $35 *
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Adocia
- 28 May 2015 According to an Adocia media release, complete data from this trial will be presented at the 75th Scientific Sessions of the American Diabetes Association (ADA).
- 13 Dec 2014 Last checked against ClinicalTrials.gov record.
- 09 Dec 2014 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History